Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

22.31
+0.30001.36%
Volume:1.35M
Turnover:30.79M
Market Cap:1.33B
PE:-9.28
High:23.43
Open:21.41
Low:21.27
Close:22.01
52wk High:40.65
52wk Low:11.70
Shares:59.49M
Float Shares:35.21M
Volume Ratio:1.39
T/O Rate:3.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:3.75
PE(LYR):-11.09

Loading ...

Tyra Biosciences : Bofa Global Research Raises Price Objective to $42.00 From $37.00

THOMSON REUTERS
·
Jun 10

Analyst Initiates Buy on Tyra Biosciences, Citing De-Risked Dabogratinib Program and Attractive Entry Ahead of Key Bladder Cancer Data

TIPRANKS
·
Jun 10

Barclays Keeps Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
Jun 03

Tyra Biosciences Shareholders Reelect Directors and Ratify Auditor

TIPRANKS
·
Jun 03

Tyra Biosciences stockholders elect three Class II directors at annual meeting

Reuters
·
Jun 03

Tyra Biosciences Rated Buy on Anticipation of Interim SURF302 Dabogratinib Data in FGFR3‑Driven NMIBC

TIPRANKS
·
May 26

Assessing Tyra Biosciences (TYRA) Valuation After Wider Losses And Progress In Dabogratinib Trials

Simply Wall St.
·
May 21

Stock Track | Tyra Biosciences Plummets 5.08% Intraday After Wolfe Research Initiates Coverage with Peer Perform Rating

Stock Track
·
May 20

Tyra Biosciences Initiated at Peer Perform by Wolfe Research

Dow Jones
·
May 19

Tyra Biosciences initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
May 19

Is Tyra Biosciences’ (TYRA) Dabogratinib 3×3 Focus Reframing Its Risk Reward Profile?

Simply Wall St.
·
May 16

Jefferies Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Bank of America Securities Keeps Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
May 14

Tyra Biosciences Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
May 14

Tyra Bioscience (TYRA) Gets a Buy from Barclays

TIPRANKS
·
May 14

Tyra Biosciences reports Q1 EPS (64c), consensus (59c)

TIPRANKS
·
May 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA)

TIPRANKS
·
May 13

Earnings Flash (TYRA) Tyra Biosciences Posts Q1 Net Loss $0.64 a Share, vs. FactSet Est of $0.59 Loss

MT Newswires Live
·
May 13

Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate

Benzinga Earnings
·
May 13

Tyra Biosciences Q1 FY26 net loss widens to $39.31 million

Reuters
·
May 13